Detalles de la búsqueda
1.
¹8F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations.
Eur J Nucl Med Mol Imaging
; 41(3): 428-37, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24196916
2.
Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma.
Eur J Nucl Med Mol Imaging
; 41(9): 1735-43, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24811577
3.
HER2-positive breast cancer: ¹8F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy.
Eur J Nucl Med Mol Imaging
; 41(8): 1525-33, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24647576
4.
Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer.
Eur J Nucl Med Mol Imaging
; 41(3): 416-27, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24258007
5.
Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer.
Breast Cancer Res Treat
; 130(3): 845-54, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21918836
6.
Percutaneous thermal ablation of lung metastases from thyroid carcinomas. A retrospective multicenter study of 107 nodules. On behalf of the TUTHYREF network.
Endocrine
; 72(3): 798-808, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33770383
7.
FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST.
PLoS One
; 13(7): e0199529, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30011328
8.
Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine.
Oncotarget
; 8(24): 39167-39176, 2017 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28389624
9.
18F-FDG PET-Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer.
J Nucl Med
; 57(11): 1707-1712, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27103025
10.
Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer.
J Nucl Med
; 45(6): 988-94, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15181134
11.
Sensitivity and specificity of thallium-201 scintigraphy for the diagnosis of malignant vertebral fractures.
Eur J Radiol
; 51(3): 274-8, 2004 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-15294337
12.
In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
J Nucl Med
; 54(8): 1244-50, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23674577
13.
Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors.
J Nucl Med
; 53(4): 512-20, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22343501
14.
Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients.
J Clin Endocrinol Metab
; 97(5): 1526-35, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22344193
15.
Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.
J Clin Oncol
; 28(7): 1190-5, 2010 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20124179
16.
[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy.
Eur J Nucl Med Mol Imaging
; 34(12): 1915-24, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17579854
Resultados
1 -
16
de 16
1
Próxima >
>>